Fluphenazine (Prolixin) Can Cause Tachycardia and Blood Pressure Fluctuations, Not Bradycardia or Hypotension in Most Cases
Fluphenazine typically causes tachycardia rather than decreasing pulse, and while it can cause blood pressure fluctuations including both hypertension and hypotension, it is less likely to cause hypotension compared to other phenothiazines. 11
Cardiovascular Effects of Fluphenazine
Heart Rate Effects
Fluphenazine generally increases heart rate rather than decreasing it:
- The FDA label explicitly lists tachycardia as an autonomic adverse reaction that can occur with fluphenazine 1
- Research demonstrates small increases in pulse rate during fluphenazine treatment 2
- One study showed fluphenazine attenuated heart rate response to tasks but did not affect baseline heart rate level 3
Important caveat: While rare, bradycardia has been reported in isolated case reports. One 2022 case documented severe bradycardia (46 bpm) developing 36 hours after fluphenazine decanoate administration, which resolved after discontinuation 4. This represents an uncommon but serious adverse event requiring cardiac monitoring.
Blood Pressure Effects
The blood pressure effects are variable and unpredictable:
- The FDA label states "hypertension and fluctuations in blood pressure have been reported with fluphenazine" 1
- Hypotension has "rarely presented a problem" with fluphenazine compared to other phenothiazines 11
- Fluphenazine is "less likely than some of the older phenothiazines to produce hypotension" 1
- However, patients with pheochromocytoma, cerebrovascular disease, renal insufficiency, or severe cardiac conditions (like mitral insufficiency) are "particularly prone to hypotensive reactions" 1
Research findings show:
- No significant blood pressure changes occurred in one study of depot fluphenazine 2
- In polytrauma patients, fluphenazine reduced mean arterial pressure, which could be avoided with volume administration 5
Clinical Monitoring Recommendations
Close cardiac monitoring is essential when initiating fluphenazine, particularly:
- Monitor baseline heart rate and blood pressure before starting treatment
- Watch for tachycardia (more common) or rare bradycardia (potentially serious)
- Be especially vigilant in patients with pre-existing cardiovascular disease, cerebrovascular disease, or renal insufficiency
- Monitor for QT prolongation and conduction abnormalities, as fluphenazine has been associated with T-wave abnormalities and potential Torsades de Pointes risk 6
Management of Severe Hypotension (If It Occurs)
If severe hypotension develops 1:
- Institute supportive measures immediately
- Use intravenous vasopressor drugs
- Norepinephrine is the most suitable vasopressor
- Never use epinephrine - phenothiazines reverse epinephrine's action, causing further blood pressure reduction
The evidence clearly indicates fluphenazine's cardiovascular profile differs from typical antihypertensive agents - it does not reliably decrease pulse or blood pressure and may actually increase both parameters in many patients.